Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.
A small but variable subgroup of patients with myasthenia gravis (MG) who have antibodies to muscle-specific kinase (MuSKAb-MG) can present with distinct phenotypes and are often treatment-resistant. The prevalence, clinical phenotypes and outcomes of treatment of patients with MuSKAb-MG in Thailand...
Κύριοι συγγραφείς: | Witoonpanich, R, Dejthevaporn, C, Pulkes, T, Tunlayadechanont, S, Boonkongchuen, P, Pongpakdee, S, Vincent, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2013
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand
ανά: Witoonpanich, R, κ.ά.
Έκδοση: (2013) -
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
ανά: Keritam, O, κ.ά.
Έκδοση: (2024) -
Antibodies against muscle-specific kinase in juvenile myasthenia gravis.
ανά: Anlar, B, κ.ά.
Έκδοση: (2003) -
Radiological Characteristics of Extraocular Muscles in Myasthenia Gravis Patients with Ocular Manifestations: A Case–Control Study
ανά: Lueangaram S, κ.ά.
Έκδοση: (2021-06-01) -
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
ανά: Omar Keritam, κ.ά.
Έκδοση: (2024-12-01)